Disclosed are selective phosphodiesterase inhibitor compounds shown in formula (I) or (II) for treating Erectile Dysfunction the pharmaceutically acceptable salts and configurational isomers thereof. In the formula the substituents R R R R and Rare defined as in the specification. Also disclosed are a medical composition comprising compounds of formula (I) or (II) and the use of these compounds for preparing a drug treating or preventing male Erectile Dysfunction.
